Related Experiment Videos
Amphetamine- type reinforcement by dopaminergic agonists in the rat
Psychopharmacology
|July 19, 1978
Summary
Dopamine agonists like apomorphine and piribedil reduce d-amphetamine intake in rats by extending drug satiation. These findings highlight the critical role of dopamine pathways in mediating the reinforcing effects of amphetamines.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- D-amphetamine is a widely abused stimulant drug with significant reinforcing properties.
- The reinforcing effects of amphetamines are thought to be mediated, in part, by actions within the dopaminergic system.
- Understanding the neurobiological mechanisms underlying amphetamine reinforcement is crucial for developing effective treatments for addiction.
Purpose of the Study:
- To investigate the effects of dopaminergic agonists (apomorphine, piribedil) and an alpha noradrenergic agonist (clonidine) on intravenous d-amphetamine self-administration in rats.
- To determine if dopaminergic agonists alter amphetamine metabolism or directly substitute for amphetamine's reinforcing effects.
- To examine the role of dopamine receptor blockade in disrupting responding for dopaminergic agonists.
Main Methods:
- Rats were trained to self-administer d-amphetamine intravenously.
- The effects of systemic injections of apomorphine, piribedil, and clonidine on d-amphetamine intake were assessed.
- Brain levels of 14C-amphetamine were measured after administration of dopaminergic agonists.
- Drug substitution and blockade studies using (+)-butaclamol were conducted.
Main Results:
- Dopaminergic agonists apomorphine and piribedil decreased d-amphetamine self-administration in a dose-dependent manner, mimicking the effects of amphetamine itself.
- Clonidine did not produce similar suppressive effects on amphetamine intake.
- Apomorphine and piribedil did not alter amphetamine metabolism, and rats readily self-administered these agonists when substituted for amphetamine.
- (+)-Butaclamol disrupted responding for apomorphine and piribedil, confirming the involvement of dopaminergic pathways.
Conclusions:
- Dopaminergic agonists suppress amphetamine intake by extending drug satiation, suggesting a shared mechanism with amphetamine.
- The reinforcing properties of amphetamine are strongly linked to its actions within the dopaminergic synapse.
- These findings provide further evidence for the critical role of the dopamine system in mediating the rewarding effects of psychostimulants.